10Q

0001393905-12-000636.txt : 20121114 0001393905-12-000636.hdr.sgml : 20121114 20121114121055 ACCESSION NUMBER: 0001393905-12-000636 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20120930 FILED AS OF DATE: 20121114 DATE AS OF CHANGE: 20121114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GAIA REMEDIES, INC. CENTRAL INDEX KEY: 0001522787 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-RETAIL STORES, NEC [5990] IRS NUMBER: 383832726 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-174894 FILM NUMBER: 121202373 BUSINESS ADDRESS: STREET 1: 13140 70TH LANE NE CITY: KIRKLAND STATE: WA ZIP: 98034 BUSINESS PHONE: (425) 224-2471 MAIL ADDRESS: STREET 1: 13140 70TH LANE NE CITY: KIRKLAND STATE: WA ZIP: 98034 10-Q 1 gaia_10q.htm QUARTERLY REPORT 10Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________________

FORM 10-Q

____________________________

[X] QUARTERLY REPORT PURSUANT SECTION 13 OR 15(D) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2012

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission File # 333-174894

GAIA REMEDIES, INC.

(Exact name of small business issuer as specified in its charter)

Nevada

(State or other jurisdiction of incorporation or organization)

38-3832726

(IRS Employer Identification Number)

13140 70th Lane NE, Kirkland, Washington 98034

(Address of principal executive offices)

(425) 224-2471

(Issuer’s telephone number)

Indicate by check mark whether the registrant(1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 day. [X] Yes [ ] No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer [ ]	Accelerated filer [ ]
Non-accelerated filer [ ] (Do not check if a smaller reporting company)	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). [X] Yes [ ] No

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. The issuer had 5,557,500 shares of common stock issued and outstanding as of November 7, 2012.

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

GAIA REMEDIES, INC.

(A DEVELOPMENT STAGE COMPANY)

BALANCE SHEETS

As of September 30, 2012 and March 31, 2012


ASSETS	September 30, 2012		March 31, 2012
	(unaudited)
Current assets
Cash	$	1,571	$	12,686
Total current assets		1,571		12,686
Total assets	$	1,571	$	12,686

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued liabilities	$	750	$	-
Total current liabilities		750		-
Total liabilities		750		-


STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 100,000,000 shares authorized, 5,557,500 shares issued and outstanding		5,558		5,558
Additional paid in capital		40,992		40,992
Deficit accumulated during the development stage		(45,729)		(33,864)
Total stockholders’ equity		821		12,686

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,571	$	12,686

See accompanying notes to financial statements.

GAIA REMEDIES, INC.

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF OPERATIONS

For the three months and six months ended September 30, 2012 and 2011 and

for the period from December 15, 2010 (Inception) through September 30, 2012

(unaudited)


	Three months ended September 30, 2012		Three months ended September 30, 2011		Six months ended September 30, 2012		Six months ended September 30, 2011		Inception through September 30, 2012
General and administrative expenses:
Professional fees	$	3,088	$	4,781	$	9,216	$	19,085	$	38,484
Other		1,461		1,338		2,649		2,407		7,245
Total general and administrative expenses		4,549		6,119		11,865		21,492	$	45,729

Net loss	$	(4,549)	$	(6,119)	$	(11,865)	$	(21,492)	$	(45,729)

Net loss per share:
Basic and diluted	$	(0.00)	$	(0.00)	$	(0.00)	$	(0.00)

Weighted average shares outstanding:

Basic and diluted		5,557,500		5,557,500		5,557,500		5,557,500

See accompanying notes to financial statements.

GAIA REMEDIES, INC.

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF CASH FLOWS

For the six months ended September 30, 2012 and 2011 and

for the period from December 15, 2010 (Inception) through September 30, 2012

(unaudited)


	Six months ended September 30, 2012		Six months ended September 30, 2011		Inception through September 30, 2012

CASH FLOWS FROM OPERATIONS
Net loss	$	(11,865)	$	(21,492)	$	(45,729)
Adjustments to reconcile net loss to cash used by operating activities
Increase in accrued expenses		750		1,948		750
CASH FLOWS USED IN OPERATING ACTIVITIES		(11,115)		(19,544)		(44,979)

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from sale of common stock		-		-		46,550

CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		-		-		46,550

NET CHANGE IN CASH		(11,115)		(19,544)		1,571

Cash, beginning of period		12,686		41,822		-
Cash, end of period	$	1,571	$	22,278	$	1,571

SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid	$	-	$	-	$	-

Income tax paid	$	-	$	-	$	-

See accompanying notes to financial statements.

GAIA REMEDIES, INC.

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

September 30, 2012

(unaudited)

NOTE 1 - NATURE OF BUSINESS

Nature of Business

Gaia Remedies, Inc. (“Gaia” or the “Company”) was incorporated in Nevada on December 15, 2010. Gaia is in the business of the online retail sale of all natural pet remedies. Gaia is a development stage company and has not yet realized any revenues from its planned or any other operations.

The accompanying unaudited interim financial statements have been prepared by the Company pursuant to the rules and regulations of the United States Securities and Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K. Certain information and disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these financial statements have been included. Such adjustments consist of normal recurring adjustments. Operating results for the six months ended September 30, 2012 are not necessarily indicative of the results that may be expected for the full year ending March 31, 2013.

NOTE 2 - GOING CONCERN

Gaia has a net loss and has a deficit accumulated during the development stage of $45,729 as of September 30, 2012. Gaia's financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, Gaia has no current source of revenue, which raises substantial doubt about the Company’s ability to continue as a going concern. Without realization of additional capital, it would be unlikely for Gaia to continue as a going concern. Gaia’s management plans on raising cash from public or private debt or equity financing, on an as needed basis and in the longer term, revenues from the operations of its online retail business. Gaia’s ability to continue as a going concern is dependent on these additional cash financings, and, ultimately, upon achieving profitable operations through the operation of its online retail business or otherwise.

NOTE 3 - ADVANCE FROM SHAREHOLDER

A shareholder of the Company has offered a shareholder loan facility up to $100,000. The loan facility is unsecured and bears interest at 5% per annum and is payable on demand after June 30, 2013. As of September 30, 2012, the amount outstanding under the shareholder loan facility was $ nil.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

Forward-looking statements

This quarterly report on Form 10-Q contains "forward-looking statements" relating to the registrant which represent the registrant's current expectations or beliefs, including statements concerning registrant’s operations, performance, financial condition and growth. For this purpose, any statement contained in this quarterly report on Form 10-Q that are not statements of historical fact are forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "anticipation", "intend", "could", "estimate", or "continue" or the negative or other comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, such as credit losses, dependence on management and key personnel and variability of quarterly results, ability of registrant to continue its growth strategy and competition, certain of which are beyond the registrant's control. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, actual outcomes and results could differ materially from those indicated in the forward-looking statements.

The following discussion and analysis should be read in conjunction with the information set forth in the Company’s audited financial statements for the period ended March 31, 2012.

Overview

We are a development stage company with plans to enter into the business of the online retail sale of herbal and homeopathic pet remedies, healthy organic pet treats and pet accessories. We plan to sell products consisting of a wide variety of healthy living and wellness products for animals, such as vitamins, dietary supplements, herbal tinctures, flower remedies, homeopathic remedies, as well as pet treats like: chicken, liver, and beef dog treats, bully sticks and dog chews. We intend to sell these products through an internet website located at www.gaiaremedies.com (the "Website").

Our company, based in Kirkland, Washington, was incorporated under the laws of Nevada on December 15, 2010. Our principal executive offices are located at 13140 70th Lane NE, Kirkland, Washington and our telephone number is (425) 224-2471. Our website address is www.gaiaremedies.com.

Plan of Operation

Our plan of operation is to finish construction of our website and commence selling our product line.

Results of Operations

Six Months Ended September 30, 2012 and 2011

Revenues

We did not generate any revenues during the reporting period.

Expenses

We incurred operating expenses in the amount of $11,865 during the six months ended September 30, 2012 compared to $21,492 for the corresponding period in 2011.

Net Loss

We incurred a net loss of $11,865 during the six months ended September 30, 2012, compared to a net loss of $21,492 for the corresponding period in 2011.

Three Months Ended September 30, 2012 and 2011

Revenues

We did not generate any revenues during the reporting period.

Expenses

We incurred operating expenses in the amount of $4,549 during the three months ended September 30, 2012 compared to $6,119 for the corresponding period in 2011.

Net Loss

We incurred a net loss of $4,549 during the three months ended September 30, 2012, compared to a net loss of $6,119 for the corresponding period in 2011.

LIQUIDITY AND CAPITAL RESOURCES

Since its inception, the Company has financed its cash requirements from the sale of common stock. Uses of funds have included activities to establish our business, professional fees and other general and administrative expenses.

The Company’s principal sources of liquidity as of September 30, 2012 consisted of $1,571 in cash and cash equivalents and a shareholder loan facility up to $100,000 from a director and principal shareholder.

Under the shareholder loan facility from Peter P. Hedly, loan advances to or on behalf of the Company bear interest at 5% per annum. The Company is required to repay the outstanding principal and interest at any time after June 30, 2013, on demand. Prepayment of all or a portion of the outstanding principal and interest may be made by the Company at any time without notice, bonus or penalty.

The amount outstanding under shareholder loan facilities was $ nil as of September 30, 2012.

We believe the Company will have adequate resources to implement its strategic objectives in upcoming quarters. Due to our lack of operating history and present inability to generate revenues, however, our auditors have stated their opinion that there currently exists substantial doubt about our ability to continue as a going concern.

Material Events and Uncertainties

Our operating results are difficult to forecast. Our prospects should be evaluated in light of the risks, expenses and difficulties commonly encountered by comparable exploration stage companies.

There can be no assurance that we will successfully address such risks, expenses and difficulties.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures

As of the end of the period covered by this report (the “Evaluation Date”), the Company carried out an evaluation, under the supervision and with the participation of the Company's Principal Executive Officer and Principal Financial Officer (the “Certifying Officers”) of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in rules 13a-15(e) and 15d-15(e)) under the Exchange Act. Based on that evaluation, the Certifying Officers have concluded that, as of the Evaluation Date, the disclosure controls and procedures in place were adequate to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported on a timely basis in accordance with applicable rules and regulations.

Internal control over financial reporting

The Certifying Officers reviewed our internal control over financial reporting (as defined in rules 13a-15(f) and 15d-15(f)) under the Exchange Act as of the Evaluation Date and concluded that no changes occurred in such control or in other factors during the quarter ended September 30, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

There is no litigation pending or threatened by or against us.

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The Company did not make any sales of equity securities during the quarter.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

The Company has no senior securities outstanding.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

During the quarter ended September 30, 2012, no matters were submitted to a vote of the Company's security holders, through the solicitation of proxies or otherwise.

ITEM 5. OTHER INFORMATION

(a) No matters arose during the quarter which required the Company to report any information through the filing of a current report on Form 8-K.

(b) During the quarter there were no material changes to the procedures by which security holders may recommend nominees to the registrant’s board of directors.

ITEM 6. EXHIBITS

EXHIBIT INDEX


Number	Exhibit Description

3.1	Articles of Incorporation of Gaia Remedies, Inc. *

3.2	Bylaws of Gaia Remedies, Inc.*

31.1	Certificate of principal executive officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2	Certificate of principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1	Certificate of principal executive officer and principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

* Filed as an exhibit to our registration statement on Form S-1 filed June 15, 2011 and incorporated herein by this reference

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

GAIA REMEDIES, INC.

/s/ Peter P. Hedly

Peter P. Hedly

President (Principal Executive Officer) and Treasurer (Principal Financial Officer)

November 13, 2012

EX-31.1 2 gaia_ex311.htm CERTIFICATION ex31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Peter P. Hedly, President, certify that:

I have reviewed this quarterly report on Form 10-Q of Gaia Remedies, Inc. (the “Company”);

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

The Company’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

The Company’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls over financial reporting.

Date: November 13, 2012

/s/ Peter P. Hedly

Peter P. Hedly

President (Principal Executive Officer)

EX-31.2 3 gaia_ex312.htm CERTIFICATION ex31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Peter P. Hedly, Treasurer, certify that:

I have reviewed this quarterly report on Form 10-Q of Gaia Remedies, Inc. (the “Company”);

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls over financial reporting.

Date: November 13, 2012

/s/ Peter P. Hedly

Peter P. Hedly

President (Principal Financial Officer)

EX-32.1 4 gaia_ex321.htm CERTIFICATION ex32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, the undersigned, Peter P. Hedly, President (Principal Executive Officer) and Treasurer (Principal Financial Officer) of Gaia Remedies, Inc. (the "Company"), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:

(1)

The Quarterly Report on Form 10-Q of the Company for the fiscal period ended September 30, 2012 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of § 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the periods covered in the Report.

/s/ Peter P. Hedly

Peter P. Hedly

President (Principal Executive Officer)

Treasurer (Principal Financial Officer)

November 13, 2012

This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report, and “accompanies” such Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report to which it relates), notwithstanding any general incorporation language contained in such filing. A signed original of this written statement required by § 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 5 gair-20120930.xml 10-Q 2012-09-30 false GAIA REMEDIES, INC. 0001522787 --03-31 Smaller Reporting Company Yes No Yes 2013 Q2 5557500

1571

12686

1571

12686

1571

12686

750

5558

40992

-45729

-33864

821

12686

1571

12686

0.001

100000000

5557500

3088

4781

9216

19085

38484

1461

1338

2649

2407

7245

4549

6119

11865

21492

45729

-4549

-6119

-11865

-21492

-45729

0.00

5557500

-11865

-21492

-45729

750

1948

750

-11115

-19544

-44979

46550

-11115

-19544

1571

12686

41822

22278

1571

NOTE 1 - NATURE OF BUSINESS   Nature of Business   Gaia Remedies, Inc. (Gaia or the Company) was incorporated in Nevada on December 15, 2010. Gaia is in the business of the online retail sale of all natural pet remedies. Gaia is a development stage company and has not yet realized any revenues from its planned or any other operations.    The accompanying unaudited interim financial statements have been prepared by the Company pursuant to the rules and regulations of the United States Securities and Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the Companys Annual Report on Form 10-K.  Certain information and disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these financial statements have been included.  Such adjustments consist of normal recurring adjustments. Operating results for the six months ended September 30, 2012 are not necessarily indicative of the results that may be expected for the full year ending March 31, 2013.

NOTE 2 - GOING CONCERN   Gaia has a net loss and has a deficit accumulated during the development stage of $45,729 as of September 30, 2012.  Gaia's financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.  However, Gaia has no current source of revenue, which raises substantial doubt about the Companys ability to continue as a going concern. Without realization of additional capital, it would be unlikely for Gaia to continue as a going concern.  Gaias management plans on raising cash from public or private debt or equity financing, on an as needed basis and in the longer term, revenues from the operations of its online retail business. Gaias ability to continue as a going concern is dependent on these additional cash financings, and, ultimately, upon achieving profitable operations through the operation of its online retail business or otherwise.

NOTE 3 - ADVANCE FROM SHAREHOLDER   A shareholder of the Company has offered a shareholder loan facility up to $100,000.  The loan facility is unsecured and bears interest at 5% per annum and is payable on demand after June 30, 2013. As of September 30, 2012, the amount outstanding under the shareholder loan facility was $ nil.

45729

A shareholder of the Company has offered a shareholder loan facility up to $100,000. The loan facility is unsecured and bears interest at 5% per annum and is payable on demand after June 30, 2013

0001522787 2012-07-01 2012-09-30 0001522787 2012-09-30 0001522787 2012-03-31 0001522787 2011-07-01 2011-09-30 0001522787 2012-04-01 2012-09-30 0001522787 2011-04-01 2011-09-30 0001522787 2010-12-15 2012-09-30 0001522787 2011-03-31 0001522787 2011-09-30 0001522787 2012-10-01 2013-06-30 shares iso4217:USD iso4217:USD shares

EX-101.SCH 6 gair-20120930.xsd 000060 - Disclosure - NATURE OF BUSINESS link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - STATEMENTS OF OPERATIONS (unaudited) link:presentationLink link:definitionLink link:calculationLink 000090 - Disclosure - GOING CONCERN (Details) link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - BALANCE SHEETS (unaudited) link:presentationLink link:definitionLink link:calculationLink 000030 - Statement - BALANCE SHEETS (unaudited) (parenthetical) link:presentationLink link:definitionLink link:calculationLink 000080 - Disclosure - ADVANCE FROM SHAREHOLDER link:presentationLink link:definitionLink link:calculationLink 000050 - Statement - STATEMENTS OF CASH FLOWS (unaudited) link:presentationLink link:definitionLink link:calculationLink 000070 - Disclosure - GOING CONCERN link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000100 - Disclosure - ADVANCE FROM SHAREHOLDER (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 gair-20120930_cal.xml EX-101.DEF 8 gair-20120930_def.xml EX-101.LAB 9 gair-20120930_lab.xml Net Loss Net Loss Statement Entity Voluntary Filers CASH FLOWS FROM OPERATIONS Other Professional fees Total current liabilities Total current liabilities Entity Registrant Name CASH FLOWS USED IN OPERATING ACTIVITIES CASH FLOWS USED IN OPERATING ACTIVITIES Statement of Cash Flows General and administrative expenses: Common stock, shares issued Document Period End Date Amendment Flag Loan facility Income tax paid Income tax paid Cash, beginning of period Cash, beginning of period Cash, end of period CASH FLOWS PROVIDED BY FINANCING ACTIVITIES CASH FLOWS PROVIDED BY FINANCING ACTIVITIES Balance Sheet Additional paid in capital Current Fiscal Year End Date Adjustments to reconcile net loss to cash used by operating activities Weighted average shares outstanding, basic and diluted Weighted average shares outstanding, basic and diluted Deficit accumulated during the development stage Commitments Cash Entity Current Reporting Status Increase in accrued expenses Total general and administrative expenses Total general and administrative expenses Entity Central Index Key Document Fiscal Year Focus Deficit accumulated during the development stage {1} Deficit accumulated during the development stage Details Common stock, shares authorized TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Total stockholders' equity Total stockholders' equity Statement {1} Statement Entity Filer Category NET LOSS NET LOSS Net loss per share, basic and diluted Net loss per share, basic and diluted Accounts payable and accrued liabilities Current assets NET CHANGE IN CASH Proceeds from sale of common stock Entity Common Stock, Shares Outstanding Current liabilities LIABILITIES AND STOCKHOLDERS' EQUITY Document Fiscal Period Focus Entity Well-known Seasoned Issuer GOING CONCERN Notes SUPPLEMENTAL CASH FLOW INFORMATION CASH FLOWS FROM FINANCING ACTIVITIES Common stock, $.001 par value, 100,000,000 shares authorized, 5,557,500 shares issued and outstanding STOCKHOLDERS' EQUITY Total assets Total assets Income Statement Common stock, shares outstanding Total current assets Total current assets Document Type Document and Entity Information ADVANCE FROM SHAREHOLDER NATURE OF BUSINESS Interest paid Interest paid Common stock, par value Total liabilities Total liabilities ASSETS Statement of Financial Position EX-101.PRE 10 gair-20120930_pre.xml XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 R9.htm IDEA: XBRL DOCUMENT

GOING CONCERN (Details) (USD $)	Sep. 30, 2012
Deficit accumulated during the development stage	$ 45,729

EXCEL 13 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F9&1C930S-U]F938W7S0Y8CE?8F-C85]E-F(W M-&)A-#DW,S0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%$5D%.0T5?1E)/35]32$%214A/3$1%4CPO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D=/24Y'7T-/3D-%4DY?1&5T86EL M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I!8W1I=F53:&5E M=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF M72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U M;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T M7V9D9&-E-#,W7V9E-C=?-#EB.5]B8V-A7V4V8C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!);F9O M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA2!#;VUM M;VX@4W1O8VLL(%-H87)E2!#=7)R96YT(%)E<&]R=&EN9R!3=&%T M=7,\+W1D/@T*("`@("`@("`\=&0@8VQA2!&:6QE3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]F9&1C930S-U]F938W7S0Y8CE?8F-C85]E M-F(W-&)A-#DW,S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9F1D M8V4T,S=?9F4V-U\T.6(Y7V)C8V%?939B-S1B830Y-S,T+U=O'0O:'1M;#L@8VAA6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,\+W1D/@T* M("`@("`@("`\=&0@8VQAF5D+"`U+#4U-RPU,#`@ M3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F9&1C930S-U]F938W7S0Y8CE?8F-C85]E-F(W-&)A-#DW,S0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9F1D8V4T,S=?9F4V-U\T.6(Y7V)C M8V%?939B-S1B830Y-S,T+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB M'0^)FYB"!P86ED/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ:G5S M=&EF>3X\8CY.871U'0M86QI9VXZ M:G5S=&EF>3XF;F)S<#L\+W`^(#QP('-T>6QE/3-$;6%R9VEN.C!I;CMM87)G M:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y/D=A:6$@4F5M M961I97,L($EN8RX@*"8C,30W.T=A:6$F(S$T.#L@;W(@=&AE("8C,30W.T-O M;7!A;GDF(S$T.#LI('=A65T(')E86QI>F5D(&%N>2!R979E;G5E2!O=&AE6QE/3-$;6%R9VEN.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X M="UA;&EG;CIJ=7-T:69Y/B9N8G-P.SPO<#X@/'`@6EN9R!U;F%U9&ET960@:6YT97)I;2!F:6YA;F-I86P@ M&-H86YG92!#;VUM:7-S M:6]N(&%N9"!S:&]U;&0@8F4@28C,30V.W,@06YN=6%L(%)E M<&]R="!O;B!&;W)M(#$P+4LN("8C,38P.T-E2!A8V-E<'1E9"!I M;B!T:&4@56YI=&5D(%-T871E'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0M86QI9VXZ:G5S=&EF>3X\8CY.3U1%(#(@+2!'3TE.1R!#3TY#15)./"]B M/CPO<#X@/'`@'0M86QI9VXZ M:G5S=&EF>3Y'86EA(&AA2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@87!P M;&EC86)L92!T;R!A(&=O:6YG(&-O;F-E2!F:6YA;F-I;F2P@=7!O M;B!A8VAI979I;F<@<')O9FET86)L92!O<&5R871I;VYS('1H'1087)T7V9D9&-E-#,W7V9E-C=?-#EB.5]B8V-A7V4V8C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!U<"!T;R`D,3`P+#`P,"X@5&AE(&QO86X@9F%C:6QI='D@ M:7,@=6YS96-U6%B;&4@;VX@9&5M86YD(&%F=&5R($IU;F4@,S`L(#(P M,3,\'1087)T7V9D9&-E-#,W7V9E-C=?-#EB.5]B8V-A7V4V8C XML 14 R8.htm IDEA: XBRL DOCUMENT

ADVANCE FROM SHAREHOLDER	3 Months Ended
Sep. 30, 2012
Notes
ADVANCE FROM SHAREHOLDER	NOTE 3 - ADVANCE FROM SHAREHOLDER A shareholder of the Company has offered a shareholder loan facility up to $100,000. The loan facility is unsecured and bears interest at 5% per annum and is payable on demand after June 30, 2013. As of September 30, 2012, the amount outstanding under the shareholder loan facility was $ nil.

ADVANCE FROM SHAREHOLDER

3 Months Ended

Sep. 30, 2012

Notes

ADVANCE FROM SHAREHOLDER

NOTE 3 - ADVANCE FROM SHAREHOLDER

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 1-4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Article 4

+ Details

XML 15 R2.htm IDEA: XBRL DOCUMENT

BALANCE SHEETS (unaudited) (USD $)	Sep. 30, 2012	Mar. 31, 2012
Current assets
Cash	$ 1,571	$ 12,686
Total current assets	1,571	12,686
Total assets	1,571	12,686
Current liabilities
Accounts payable and accrued liabilities	750
Total current liabilities	750
Total liabilities	750
Commitments
STOCKHOLDERS' EQUITY
Common stock, $.001 par value, 100,000,000 shares authorized, 5,557,500 shares issued and outstanding	5,558	5,558
Additional paid in capital	40,992	40,992
Deficit accumulated during the development stage	(45,729)	(33,864)
Total stockholders' equity	821	12,686
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 1,571	$ 12,686

ZIP 16 0001393905-12-000636-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001393905-12-000636-xbrl.zip M4$L#!!0````(`&9A;D'F[KW9#PX``,=-```1`!P`9V%I;,EQTE%L.?4ED5/;:2^?.A`)26A)D`>`MG6__G9!4B(IZM5RG-9? M+(K`OCZ[6)`+G?[T$/CDCDG%0_'JP*G9!X0)-_2X&+\ZX"JT.IUVUW(.?GK] MSW^?W4PT3HZJ=?QLA;* M<1W('-63FP?)T-D8))L?UZQSH33*F8X\B94UIC2:S1A1-32CTQMUE,^R':OI M9%-\+OYAN'>YF`Q\4+PR\;V;#G/I_/KR_<2'&*4T^4L<(U&Q%#ZD1/(_;J0/$@\E%B\]U$ MLM&K`S"$M#+E:P_*.R!U0P?D/CD/W3A@0M_"=.*&0K,'?8VS/CN-7YH'KQW; M^N6T7AZY,/TCDSST^L([I[J23F*?KM6TB]0*$V=D>W#+P]L7/AU7D1M17[&$ M4F'LC$)?:*ZGUVS,E8:@U0,:5,KUMG?9(]?]#_WSR_X-1.?@K):0K2)0HGX& M3"7U+X7''MZQ:15Y&S#;;C2..\=YJJ6),[)GL92H"%0;?CT-9*>Y-0'T80JY9%$J-*0Z3&!73O/0%*F63)(+,YM]H MJF-5Q>HS4P635$XL4?\U]&.AJ4Q$J"0["/-42Q-*Y'YCOO].A/?BAE$5"N9= M*A6#]NNE73)S(2SF#KF`;RH%AL!H%D.B-&D)T21PEI+]I5%%-#>I[+@P"$)A M5KF;">1-=15K3'^X2!*/N1R0`#BH,"N;]B16/#D.IE\\+K=;A^W;;O@ MXA4LC#3I2G-R1M5D&YZ?;LXA4;6/(1CR)+:FZ2S0;!QUCE80[2G%M$JA^TB) M"[1VY[).AW5L]J+%#G0WD[M(V'5#B&[UD4[IT&<]X<$W,F;>>TZ'W.<:%OY= M?0/8S?'>G%%!P'W+L3F[O?$IQA`$,->83138X`QH0N1")8T,UW$@4-2=""S1 M-%@NJT!VH5Q&RGK*:=+YE?HQV]HRD,@ZN110(O:DF\KVR@OFP;[J!ILI"I3XS)6^Q;->7K1DJJX M%^M)*/G_F+=+W>W8Z5^E1&4.^Y+$>6))S/9J)WO,]B%K:.^#?Y45]L-_7YNQ M31CL39+=S+%,DH\R'#&E3(%PP5:7N)^KTFS3[N2*JS*Y1_!R*JJJXX[S!+S. MG8;=LIW?L^>81:;=AG/T)$R=A*E3Q=3IVIWVDW"UG8;37J)JL]/JM#;D>J4G M3/8?(B;4#JAQ6DV*S&G54"WEX8K@*554+57ABN0DSY`<5RAGTJ!915*MN'O*&*NP"M M<^['>G5YNP"9\@YHSG\-E_U)Y'QE$BT'XE<@VC+([D>TWQCV,C"O=P?9:LP& M<3!D\FIDYN4*^D<`;ND&8C?63RZ]\Q>6?BF0_VIJ+`']4ZJ!6Q&N][MFS6GN MQ&J;U>J1K+99IY:P@K5+,HK/GI/_EV+Q9=ONIBV\Y]J$U9YE6[V5;G6>5;B5 MFZI'&0YJ$GQY#BZ_XQ[SWDP_*>9=BJN(83DKQCT7BMI'NA:BQG&*E=Z&/)]$ MU)51YW3;K=97(^KJJ&UUC[N/%A7&NXQYZD*&`3[PQ+ZZJU'NX=\C=DQ'[3PV MUW+:Q(077,"\/9FP).#F+!<:6)+VG7+T[2]DEO/8BRC;A,03B[+*7XN=1!L* M@JT+\`]?C=U1WS0S@*NEG()7=VL(J&A`6LMDWV(Y%6_NG4ZC\>QB+3Q;:&"C MY3.+M5%GVG927>+[>*8TMD5L'MRKVV)6T%P1I3O37!%NZVCBDXQ;^L#4?M5? M1?81%EA%=F4!+LB`W5&/DE`06#09[J:)TSXD#=NQ:\2(P'&2 M(3Y,+8S6QNM0^'!-)-.4^T1!GL0[U/>)0*]0GT1,D]D)CQDY"@EZUIX$!L,6 M*3<1E\#^G4Q`3A%J,C6SP3S8WX`W)4P3,51Z(R@="=>*1#X5`NZ"^C@@Q%=) M))Q%82U5_\A.W//71<,MV)NZJ97PU7XL:.SQQ(N0U7E`1DE]"F97V-%B>C7! MEG?@.,8$B22+J$R.3*'W4H"0*)98@VNB0_.]C'VP,/I!LC'VE)ETEKK\DS`L M3^/X_H,[H6)L2`?H@.?X1"Q=)DWNN M)X9VID^E'D@',`&D+$0"E07Q*/$DQ=3#"`_]A*N-"%?*?#,W#@. M'"<]W.8/F-LFO:9ODUR#8<(9)*-.. M&]][8'5\NY?%0T993Z@&HTT1Y.PA8JX!7MU.7A+ MSJX&9_WKP=]J9<9%B@(Z-/'QH6NV;N':9EIR,8BSGESBF:9<`X;%I0^@]&VK M?7C;U_#N_!=/*0S,PO8!%(3VTHF.J:J6F-D,DI*<=6%14/\=V`1E-Y M83P$]PS#6"];-Q()IR1=9C@0),:Y!5O4R&^0S9%,6?E9HSQQDQ[Y0ZA6R'VV M#,90./W)_"1A&G76,%IP_US4>:8VQ9#"50Z5-M/Q2)6IE:)X"#[%M0$"P5),ER\AL M$P2VP"JM6"C.G+N@RV9FQQ+28Q%F;F$6]61M*1@=]]GL@P'D^*2JW6R:R^6*'<`^QJI"JS;Y"Z"ZG^ MFID<\I%*/36GVZFIF]1\^BWDJC<^/J)][I3?A)3?._^U!^F>7%Q??2`W/_>N M^S]?O3_O7^\W^\U#X)F/\%L38OFQ`/@8:CM(=F8CA#F$2I44_@Q* M(:@]VM_!9DN:BC1(8A5*T.0T'(:(QP+\DH[PUP[^'0-PTZ6E62.])8O.85*5 M![A$D##751P+5,<44DO5P[WFMT1POSH(M@!U*1B2FC]K?<@??$G7W:W/5Q5? M>J[G4"K$!+Z\`,=P?9$J?\Z4*WEDLD7I<1BXV_G=:=I'3?O@]5/@Z`NC)Y_6 M5AK"&"TU!N'>+#W!UR].F3E];#Z_..68UOF(`ROS"PJL\*,+V2\ZG%V^*Y[= MGT]+:-9S1$\C\WH@90`XEMJ1WO@+YDQ]2V%[^I,WGV5'F;(`R9W>4E9ZS M/[NZX+#6$P95Z?G_LZOK;*#NH[Q;>"_Q[.K:%C@/7TH_5QVR35#<<-X@#WG&%BK@WXO$@YE28: M8N=,A`'LB"O(5>B;42K/.JW/I9QI=6I^:PL^_!]02P,$%`````@`9F%N0=3Y M0UVF`@``BA```!4`'`!G86ER+3(P,3(P.3,P7V-A;"YX;6Q55`D``[#0HU"P MT*-0=7@+``$$)0X```0Y`0``S9?1;MHP%(:O6ZGOX+$+-JDA!%2IH+(JA5"0 M:%(E8=O=E,8&K"8VLIT";U\[;3JR-2UK6=(;HMCG_.<_GP^)-8[BTW#,\7`GSI?P6M9O-4:S6-5@.L5JL&@O.`I;*-D,9`TY2O M")/;KOJY"3@"LB/">[6%$,NNKJND]0V+&I3-=2G6UK/`VM'AP4$:W%USG$M8 MM;-P0_]Y-?'"!8H##1,NE/V'1(Z[/%V?T#!M8(>2H#!"W6E9F*:6-*.EM8W& MFL,MHS,G8UD';5%9LEZM4XCI<1RM86#,UZ-5F(:9FX.I7/.VOK MOUL)@RA,HG1Y(N]S5=%:(`(1S.JJ!OY+KZD=_3D_>V-^84Y,NV]Y(\ORO2D) M$BC_L?"ME`O42N1:X*`RDMV+8\[\WONF+%,M]PQ2Y*I7KIC.W+OB,?6*[]?J(YM4IHYAR4 M2M(]G6J!;"=T"+Y5-[`")`$=\OX.;B58^OYF1 M#S#&>P/]LOP'&NJ=X#]N9-^>4$L#!!0````(`&9A;D$F!&UL550)``.PT*-0L-"C4'5X"P`! M!"4.```$.0$``.U=VW+C-A)]GE3E'[B3!^U6#4U?XJVQ*]X41Z)F5.617)*< MY"T%D2T)&Q+0`J`O^_4!*'%"2H)(76R"CE[&-@4T3I\#-+H)4O/3ST]1:#T` MXYB2F\;9R6G#`N+3`)/)30-S:G_\>'EEGS5^_L_WW_WT#]NV[A@-8A\":_1L M>=$,,[`&@OI_6$.&"!\#LV(N.UM>Z[/;YS$68'$Z%H^(P0?+#1X049V;-)K% M0C;N$$(?D)"C\P_R#__D@_QL]LSP9"JL?S;_99V?GGZTST_/SD^LQ\?'$P@F MB"5F3WP:6;:M<(68_'&M_ADA#I;TB/";]U,A9M>.HSH]C5AX0MG$D<8NG+3A M^^^_>_WK[<"?0H1L3+A0\.<=.;[FR?5;ZB<.E!C2 MTK90?]EI,UM=LL_.[8NSDR<>9(".<9@;9H*P)#:"``-7A#B*J=.KB]-,'V5U M2SI6NBP(.;NZNG*23[.MI;E`?&N>M7[IS#]<:HTWP/E&LA3VW5Q9Q'Q&0^C# MV%K\>M_OK(Z'B7`"'#F+-@X*P_=6`O9:/,_@YCW'T2R$]-J4P5B+(P6NE+A4 M&OR@K#E[8YI*(,R/1V#+JT#4JCL@QG76]\?\S98=P!C%H3@@XE7;!\5+(X0/ M2?"*Z0.@30S9$40C8(>$FK.;P9F"7$:X,9PX"58NMVF-_CB>_8%>.-=9>CU4-`#7^`D!(_>RHC5!M ML)0ULMXULNMJC/@H60DQMR<(S9)1'0@%3Z\D/-BG9XL=]8?%Y=\'`@E0V@[1 M*(1TA!"-(+QI:!HY%4.5JD!'_LJ+X/[5L"+(+N<@N#OB@B%?:.`N-8T6@C=>FP5(M8)KQR=#I3.%'8L"@+@,USZ4IY M;\:,J:A5AO[EMI6JL'[:K"JPXJ!Q0C01GVIX3SXR@&;-+,FR/??".')S^,O, M[IK0O>37>M[/J^9](^&U8EI'\45U%-]B-,*AY`RX3#J3^RM3&DI4W/M?+!/0 M@IA>NGL--MOR5!BW4#+0R^W%&SI4JM2VTU&CG_G[M>O[-":"WZ%GE>I+9^45 M%D.PZH4N_FUAP11-RT3*;8@Q3M;2ZM5;I/):F!$4BT6H*?L&9A1-&D58J-U6 MA?`F)0*3"1!?+\.F'C7(&S8Z;)P\6Z=X]4[JMD_C?JQVZ5"20/X%A;'N+N%* MLXIUV"9)6W71N#W<#0(\1W.'<-`A333#0D%;GX9I6M=($ZW#QFWI+7B`D,[4 MJI?+?P(>$=-7GW'DT MQT/OMW?HGEY=FT;J.LJ2.&I?:KR#MQ4(]NZN>'2^K M2[9+'<7)N5PNX3^FCKNFCH.A._2^>MWAH-?NW7E]=]CI=?=_(K+([.NEC$5( MCNGBVTL7/P,!AD)UHAI$9D`X%!P#E.U=@]A:F@CC4L<[1L?` M>8*G#=H#M95FE8JRY;S+*K7JKW&2]&2)S1:NZ/3(MZFK&$N>&I>X%[BV6URK MK5J%;!B7Y7=!=(A,5^"6IP5ZSY)1QB\9#C,B2@J?W2SXACGTY:5HX MC(6VZBWJ50-A"ATW;GW\"NI590C: MCC7UZ]7437?PI7W;^_6P)?4:J]54U&N`'`OJMU=0R[U=O;`DBY0'+&?/I^=[ M#D&']&:@4BTR<7V9<,U/@#?7UCL8JD$@WH4>X\H[58%BL2$CS32H5)/=)^-R MP9VZ:YP6;O#?F,\?M!W2/LBMS< M=YO_[)#5ETPT,Z-4UVI?2GS!99*=*^5(-"Z*E`^4>^_6?X]YL`VAQD4"#?@V M)DC2M7\.M\E0#?:#7>@Q[L:)1.\#!+PM"5#/.*@O_>J-,R?L^M2NH)^)&5^) MJ;N4\1614Y<0OL;SO1?K6Y!X&[J,"]`)X:]YB_ M`JM>>90_U$/M#RA,7H*4LXVQ9SFQ-K[$5JIO310K04*YI_U?\X9;/)O-[PJC M4(%OA_0Q\W5S16^%ENQ=`P%+$[%>PG]76<8*8,"%>FU/6ZYFFE0KQG;S+5]I M9OTT+AV9UU-#]`1\HQ+Y5O458\G;!LY^]!Q=P/*8\9=-WA?=_KM3_= M#SI=;S#8^=M/]19?\3M/]2!>D]//O4[W<[/7;7K][OY\YJQ5P64.P&ORZ+9^ M42^AM?N]KX,O;M_[TKMM>?W]&=78K8);#92J9FL+!,(A/^RD38U6/7=3',=S M\[=W;MY7VA((TD>PLM\V,/_^`8T+)3K6H-XHXWZY'/>84[W4OG6PV+K9O#F[ MV#'>OMUXJP#TQDTFYX=H(U\=S3ZW@/L,)RM.@[^H5PTB;:'CQS"K"[.+Z^H? M]5_VR"M_`E!+`P04````"`!F86Y![NQ/JC`L``00E#@``!#D!``#=75MS MV[@5?MZ=V?^`9CMU.V-906`>8N<+6!`8 MT"4B8$M993#HO^_.Z-8+$:!X&=Y#@DY!U[V#`:_G\U'K9.7]Y!N[O[\^0NX(D(GOFX#5HM;A< MOA=\>.[=H#5M>0$,N?ER1>F]H]'V,G4@!!99`6(+_KY44 M:_%/K?.7K5?G9P_430FZ]/QG;%;08X9=(]=#E!NDS2W5N7C52=7A5"N:(U=E M9Y#SBXN+=O3;=&E&S@WWQ=/47[?C7V9*>R7B[(W,&O:[MP3[:(:6(.+Y)GS< MH'^.C%[MLM0?Q_`&^2\` M+WD]&PDENWA&*Z[4;DK&*T0\[`Z"PX3-U&Y8ZGD(2:@A=ZI^8Y(OV("(#I(Y M5;,Y:7$(_<.D?:H92QN/I/S#F/WT3&CT$*+`16XB-J=3TH\C-M%(P0DGE+&3 MIGGB\Z$3DY.T)4[2X\@2TIN(YI:V5A!NHO&MC?R0)E^BN:'5.=^-E3_N/O\^ M02&;3O`:C3&E"8-(LWB$D3QEC@H0XK]\WLIR\A,)Q(S<5HG M?.)B9/G$BX+6]?SD9T80<%IOVT\LCR9DN,?*@9)VB0,P<1'9K3/2@D/B)!_8 MCQ)Q=B7:#F;SQ"9L)>:+JB\)7HM:.&&)RTS2/@Y>V3`7LHD\"!?PQL\VH*"0 M-F*+F>I`=D_1-B04JYJ%0IF!JV*!(N=LA>_:+O)B&+`?LJW//OT^"$(O?/R$ M_6W`IKK'H>>S.233:.)R!V-`REH'!C%AL*<,8M*V@$*J>X(+1;LW.JWU(+UE MN[`[CTW&EX_7%+FC8+I!A&U"@E77";T[+V3;@>X-#0ET0O'<5Y60B0GR0.%U ML-CKSC^`X7CZVQP,9]./8'HUF'47H^ED;@L<]>U3,*5IM6YS@)Z&MX@,'C8H MH$BT3GM>1AN&A2QU$!81M`U,A5IF<5)BV>8@P%"Z1)1[H*`_1$(4Y(II`T'$ M6`<+:9I@R8C:A@N1TEEHE)N[.72,/7CC^=%8U=L2PM9F`GP4%-1&B)BY#D:B M;3=P8H+`?^)AQ?\,K3P^#0?A!*ZSC2HL M9F#I7\S8P,K_B3#@E&T!ADSS_+J_S.8V+ONUE_M-+O,-+^^OYX,^&$V2%?[D M/>CV%J-/H\5H4+K6MT/!TB'7@)9V[VCT=S)']]Q-EUS2H8_O99OOTBKFO'HE M`AGQ\0&\!)P#B%C8ACT5,PC]?]*&:0Y?[U'`L.YW`[?KKKT@FHT8YM%NVR:! MFFIM;=15%%,'@#M6``8N@,^8`;3;R[ZQ#8T5S9,%YD'-V!Q&>WB]QD$4"#*_ MA0PM(TJWR!5@4E1:&X,2,;26&1%I0#GM4T`CZL"+R-L&-8D5LM!2:HVZ]C]] M[&SY>+N/4>BS`;A@`U1<3FL'5,I:!RH)81!3!HPTX+1MP8E4^?0N2,'P=6&C MR_BZG/?0AZL"3#S_O186"EGI8&!/$'"*-K5\H:KI%B\Q:Y->OP"Q-1A!KA<. MH<-=,X]]1!WB;7BLG=`%6%[+@#]022P=Y(PQ#,!R1]L6X%34/^]=J]`NS8$L MCOI8P`=$KZ`G6JUD2VF#2,!6!S0Q21#"![!A)$TZ.S2D+?5H5!#Y&$@7J)U% M=BDX&EQ_L\TJVQOP?P;_WGIWT&?C-^V&/4C(HQ>L/D%_*PHJ4JNKOS:O(J+6 M2IUQ.`4W:.4%`8]$QTNPB18O)GN%<6TVF6#7;TRQ)/I8J!9;""^U!T%/;CQV*@B M`)ZHM#;2)&)H>6WVI*,]"?`"X,34;<.9Q`A98"DU1EU^O%U`S9`A&?J?$21B M-Z^PJ)9W3R:`UBIA%P45$P> MCYZE[2RPF;#X6E@9&/+J,X#>>+F7"X08D$0R$*`0L%DK^NKP"($MC5/&<2(0 M@'N);.DF35@[/S#7C;?FNNEOB&?M([=[QT1;H'S/B)ZRFXX7RCP` MXX5=Q]FNM_'&9DN8X-D:@M'``&'MD<&<4FJ)9@\#2\[ZS!SEF3JILPX"*=V*3G*:3`O:[<-G:(,)AQ6/3MZ* MKP80%#>0)E0NB(%TH<2+LN<`8A:VH$/5%/G\(95&:33BA2#(9\3XWU'`)D6R M16XJ_TTR M6G4G,IA`7YQ`NY*G,9CA2O%#+E3"P1BEF;6!O$E$%$&C#:MN!&JGS!:J#,\'7G6#R=YPS9EZ)UI*BD MD3P+`7LCF1;IT[>(NDT8D1B@*-NBM`&:FZ%G*(1>@-P!)#SBD*8]*+%/13!) M*U34GJ?5A6O2WP;^>_X_D[.V62WO$+G!NPM*OT'GHKJQLI-X5<`VUP<7Z"&\ M9/2_2$ZN\^6T>YB0M5Z'8I;VK1F@I;IFD2*Q\Q%S;KO;\!83[S_J>;>I&N9S M;_/B&,^_A7L6ML%)P1K2/%Q1ZQSE[BVVO8E$N\4^LR3ED>QA=H.A7,WDO5RE M@FEMTJ>+[AB,1]W+T3B*?0;=21_,%]/>KQ^FX_Y@-O\3W&#Z=S#XQ_5H\;FF MN[NTU2O?JYO3\Y7:J>2V+P6`-GF5C&(/JZ-/U=2+(F\03='>(0I%+$SV MFCK[R>%:'.?J&]6>8!/V=U?OC-DZ?,1^%!U$%!0T=V52CKF9BY(,;PKUQ`WW M;U24R6P?ID4Z"R]Q$@"D7A]L=#]XCTFPPD3L@7U>RH#_M9"M`>]K1!)J'$A:4BZ#&& MK[RR11A8)^KE%U M<;52B';LP";F%P<,[")R++Y:_``SY7)_#FW6!K%+*0H3(62I*19.554J&&%Y#J6(-9O-"7&T#^ MEM"QEV2R\TYU?)57K_UX$!\B-'BX@!;@I+V]@5281 MQ<""C'-H?>$L0,(#Q$QL`I&2-?*K,*66:7*Z9..@R^\HWU^^]QZS!6&/*T^" M"<[=75:EIH%)4ED\'>"]G_*K/WO326\PF]@"L@-LD)_^*K91@_>G["52C?HN MJZ%_XXE<'"WO&;.T-5-@!9US%X^HMD&#P53;S<:/8F"@GSQD-@J6F*PAOP92 M]CR=8FW]L*MJ8FK%8EU?78T''P<3'O"ZO_`8C";#Z>QC]!R\;4BL:)Q<%-0A MC6CCQ>,2L!Y`J,&+R(TZ2YZNZ1[.IA^_L?NY97C6;>>C).:4OKN1+68R!-;IG(,-).".,S@%YYW.:2?^DT_*.06O3U^__MOIZZ=?QB_F18?\ MV#YOLLR0)2D[1WW%H;)'KTX?7KU>NZ_&2U?=+U>7)TXW_*,TWL-4@(<);,19 M&O)XCOHE5$@FL3GL1(30HB9O^KFV?72_9(@3E3;T?)M0#!T`[]Y$LS8'0Z)Z M\>-HDB8X8L*T^#Q?J8KYE&G#9_F%.=-?Q[)+>H1?O86.%#59.GN:B]HM8JD_ MESK*,9*-":PPM:I+??3(SO*9UDCT;]6#V`4C6W+V&OW:R'%KFI&1$U9.T);6 M%BE:=(J:-ZE*&Z^@1Z)V[%R\ZD2MN/3\/H9YC(:97P^OPAPDJ>1I>4=KC^$#R&N<='R(P',7;P<;@*8G< M,&YT3)$DR,J='L*:)GT?,O',N4#V!U>V@:J"-4H<(&JM=92PLQ^8M^23^RO&T@1^_)_4$L#!!0````(`&9A;D%.O.XV60H``%J3 M```5`!P`9V%I&UL550)``.PT*-0L-"C4'5X"P`! M!"4.```$.0$``.U=67/;.!)^SE3-?^!F'KQ;%5EV,IF-4_%.R3H2U3B22U*2 MW:<41+8D;"A``X"VM;]^`%)*2(K@H8N$5R\^J`;8W5\WT-UL0N]^?YR[UCTP MCBFY/KL\OSBS@-C4P61Z?88YK;UY\_JJ=GGV^[]^_NG=WVHUZXY1Q[/!L<9+ MJSU?8`;64%#[FS5BB/`),,OC$(2=PFA]TC(N_,7\A_[_(7\;+%D>#H3UM^;_[!>7ER\J;V\N'QY;CT\/)R# M,T7,G_;ZM^C!$'2TI$^/7SF1"+M_6Z&O0X9NXY9=.ZG.Q5 M?4WX_.>?GCWSB=\^O M+D)CU*P%U;$Q9*60RZNKJ[K_:9A:3N>([^3AV5_7@P]CU#B%G>]*EL`^"Y!E MU(4!3"SU^].@FT\!=45=QP[[VJ*V-P+UQ87YLQF%P_ES=BM?7D"I5?X9=9SUZPNB\@`+73-`4 M&>1*+;FA"S40N6<690ZP8!,XBO[7@HSDM`EZCWQLF+ZCHB7K^>6Q]7P'#%,I M@]-"(DWA43I#-1\3-AF"5\>"H"%9$2U;UK\=2=4^(G:<":%YWU/J#A;Y7EZWT@;9!@^>=20C-0_CXM4![O` MFM)RII3IEZTHE9%8Q`1-5OZ;([M)X,4#6%`FI$T,I1X]KG>09'(CX=")GHS+ MU7%Q^4Q=3RJ1!4:C!R1.9R02&\)JTK2+XV+P!5SW#T(?R!`0IP2<+N<>,"T6 M.GHC,=$*K\'FZ#GTC\"C(Z\D>8B.TC`\M`)KD#AZEATP%J2?^;`(TQJ-1D1H M#1[?4^YW]<2*Z-[*OC>-VT:OV1Y^:+='PT\$>0X6/VJK10N]FMF.6=K5L+"+ M;4\0'_MFXO':%*%%8.#@"KZ^$K?TU>6O*CP`A7Q_TL$$$1M+^"G'*<7?0D-W M>KVJ(2G+9;9!0;JL3]4#%X#U@(;T)NO+/^$J:0E@53")FE*C] MD'!Z!"PIPP1D@.[?09%#)L!)^R+.P:G(/@&0M!C*@JF&V86QBWN&"5 M\YJ`P54VEPN`.&W)."2;SB8&&R)6#HHFXC.-YOV/*J%HC:6$]1W(43GU1OC/ M8^'&*#PFF?[Q8=%]@0KD5F!?2`7+,)32'BT:!\\M1F/LRM`1N,P"_3KYC+I2 M'M[^TY,98<9^DGNX$5M]?F4E+:*:R@&;&S_38Y)Q3/J>3\6:J=7FT>3$O5D$XBMAS!MA!%12ZK(!^J"VZ7&5S#$-#VH+!Y& M[MPXMYO[K-IE/B/7T]7#-\A*1Z)(D+@I9.4BB(;CX(";.X2=+FFB!1:*M>0P M4$-M%"I:D2N7:[7@'ERZ4)XOEX`IM(D`MF"80PLFV,9"QJK>W'/EZN"T/"97 MX_@(#8Y[F-@HR/>A2`,VN-P;FUGH)0FJW]",BR2SRA!;5L3,PCA;"?K&\QT1 M+Z=;Y,Y7X`P$MI&[W]:1Z-3E]Y%$^2G'R6Z0JU[]',X`Q`""A1YSVZ7^N(Z?NMT!\U_KR,Y3M2.K@FYF MC2=3!95SNHV7;QJ>F%&&_P=.-F`;(TP#:E/DRF6R&]SZ3>ZYP5E1FPG,6M3* M)9`%WMS+-<1,>'*\I_?KL1K+AZ/&J/VQW1L-^YW^77O0&'7[O=T[S+.F/6:* MD,5+.:[0)9);^&Y!&?F`CKKLD-.(_Q3Q'P6[]T"`(5>U?3AS3/PC M;`2^A_;C`@B'C'4@[^BJH)RZ,>961>4<\([1"7#N\],![?/W#;*282EH>V&L M-B6N'"A],0.V$D6'2)3&7#ABLE8N^\H0;;O5S6"\,O7QA/J4>B""8.N6-Q\#ZT]\N4,EB7SH;SF9$4:QK:(.UB%PS")0LS'\T+GM?]EO M#2AAUK)*0`FLE'[J@'HIL>/2AZS'PJE#RBY&F%,+RJ/Y4T'H5!`Z5KBLC%`F MV/=8+G,WRT\RS`N_""JJ,%H+?#>O%4&9&-:]FD@SG\]'KR3,J(#L"FQL0N1['!$]^/1 M![F5$3Y_&"57KDPFI6&`5$]X\+M+-M\%U3\1S!Y:]ND#!W25L+7D4V/E]H3\ M"^W.._[_BR444>D3JN!IQ%X=H;9[#)DVD1'[R38*JESWE.3>!G!X1RI`M7BI MAF:9P?YH+]*'EAGCJAEQYC#?6,29I1Y3MH`$R7=VV*';M'KG]B@;14QI;2*%/?-\\UUAC, MOC,TDO+=R#M]R]B?TD:4E38C(=GI3U9U/4JTZ?$F8JW"$FEB.&")>\J,TJ@56-4$5F,&L!**2;RBP$ MX:VP!0)AE^]WBU]/6OY.O^:D'-?)Z_65\74#&WYS^>FIR_?4Y7O`#5*N,02< M]0M'X>,_@P-!M?MBYL"J8)M:&,ZC@`/VB98=0>]M"TV?ODKQ]&E;/6VKIVWU MM*T>MM!$5(^79!B+#K)5K^^R!=QFV!=/6V1*'U455%,WU$S1MTXE5Y^H'V/$ M05[Y"U!+`P04````"`!F86Y!"';_Q9($``"G&@``$0`<`&=A:7(M,C`Q,C`Y M,S`N>'-D550)``.PT*-0L-"C4'5X"P`!!"4.```$.0$``.U9VV[C-A!]W@+] M!]8OR@*19=G--@ZL++2QG!APK,!RVKX%M$0YQ$JDEJ1R^?N2E!3?%;N[!1:% M\Q)>YIR9X2$I8MS[_)(FX`DQCBEQ#+O9,@`B(8TPF3L&YM0\/S_KFK;Q^?+7 M7WJ_F2:X8S3*0Q2!V2OPT@PS!`)!PZ]@RB#A,6(@YQ(,O/ZU.^$Y%@AP&HMG MR-`I<*,G2!3XBJ99+J3QD!#Z!(7TSD]E)VR>RKGLE>'YHP`G5Q]!N]4Z-]LM MN]T$S\_/313-(=.TS9"FP#157#Q\1"D$,A7"'>-1B.S"LI3U"6:)UPQ9T@(Q'%:`G)MS"+,W4`SY3`/*"4N% M:;9LLV-7D`23K]N=R)@ZEIJ>08XJ\Q@G*]9SB.6ZI2C"B*M\M8=6MZ-42N0X M$0/*TCZ*89X(Q_B6PP3'&$45G_*&:_QCPH42Q``"LCD28Y@BGL$0[1M%X29" M"R?:`4=A"9 M54P::JHK^UF&24QUYT-/45Y4>DQ0#+23"[4/G`;':9:@1CGV MR%#L-.2J,+-:B8>,H::,IS)A-)&PG>NNIBT)X5)!'=%HX;BB@"S<8-E8!$E" M,\2$5.9M,S6L'Y-2A.)#4Y(03/#/FE`"9X9$4`>*(/?0Q#Q/*12M]=/;XDL37:A M5@_(?I@UW;:`RJ%J[7^D'L'4G7JWWG@:^`/_SINXTZ$_#NX)S"/Y#8X6HKQG M6*?,[TJ90*ZE_J2I]AN9$F=!!T[RBO#C4:J=1^?:'XZOK_SQE3<9]Y&`..'; M3L\VLSJ9NAL'2#.`D@**.7+E&P8WG3;<=GAWS=6*TU\],R0$* MDN-).5B..PDCXA$)+(-[3YM5XSJA.OL+!4ZR9=JC<+NO.+?_IUK$P<2_#6[< MB7?CC_K>9-LMM\.R3K+SC8NN)`&*!2S1'!6J>2]J:FVJEZ9E7R--60:;?-CMU\X9$!R-;:YXYZJ75H M`.LU9>6^J]S;G_9ROU&3_HX(*!E_;Q"4F/\ZD*7"K`K@;)?KK97`Q0````( M`&9A;D'F[KW9#PX``,=-```1`!@```````$```"D@0````!G86ER+3(P,3(P M.3,P+GAM;%54!0`#L-"C4'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`&9A M;D'4^4-=I@(``(H0```5`!@```````$```"D@5H.``!G86ER+3(P,3(P.3,P M7V-A;"YX;6Q55`4``[#0HU!U>`L``00E#@``!#D!``!02P$"'@,4````"`!F M86Y!)@7(@A,(``#!:0``%0`8```````!````I(%/$0``9V%I&UL550%``.PT*-0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` M9F%N0>[L3ZHW#P``8+4``!4`&````````0```*2!L1D``&=A:7(M,C`Q,C`Y M,S!?;&%B+GAM;%54!0`#L-"C4'5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`&9A;D%.O.XV60H``%J3```5`!@```````$```"D@3`L``00E#@``!#D!``!02P$"'@,4```` M"`!F86Y!"';_Q9($``"G&@``$0`8```````!````I('?,P``9V%I`L``00E#@``!#D!``!02P4&``````8`!@`: )`@``O#@````` ` end XML 17 R6.htm IDEA: XBRL DOCUMENT

NATURE OF BUSINESS	3 Months Ended
Sep. 30, 2012
Notes
NATURE OF BUSINESS	NOTE 1 - NATURE OF BUSINESS Nature of Business Gaia Remedies, Inc. (“Gaia” or the “Company”) was incorporated in Nevada on December 15, 2010. Gaia is in the business of the online retail sale of all natural pet remedies. Gaia is a development stage company and has not yet realized any revenues from its planned or any other operations. The accompanying unaudited interim financial statements have been prepared by the Company pursuant to the rules and regulations of the United States Securities and Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K. Certain information and disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these financial statements have been included. Such adjustments consist of normal recurring adjustments. Operating results for the six months ended September 30, 2012 are not necessarily indicative of the results that may be expected for the full year ending March 31, 2013.

NATURE OF BUSINESS

3 Months Ended

Sep. 30, 2012

Notes

NATURE OF BUSINESS

NOTE 1 - NATURE OF BUSINESS

Nature of Business

XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'

'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'

'+ "\n"+' '+ "\n"+'

'+ "\n"+'

'+raw+'

'+ "\n"+'

'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 19 R7.htm IDEA: XBRL DOCUMENT

GOING CONCERN

3 Months Ended

Sep. 30, 2012

Notes

GOING CONCERN

NOTE 2 - GOING CONCERN

XML 20 R3.htm IDEA: XBRL DOCUMENT

BALANCE SHEETS (unaudited) (parenthetical) (USD $)	Sep. 30, 2012	Mar. 31, 2012
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	5,557,500	5,557,500
Common stock, shares outstanding	5,557,500	5,557,500

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References+ Details

XML 21 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	3 Months Ended
Document and Entity Information	Sep. 30, 2012
Document and Entity Information
Entity Registrant Name	GAIA REMEDIES, INC.
Document Type	10-Q
Document Period End Date	Sep. 30, 2012
Amendment Flag	false
Entity Central Index Key	0001522787
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding	5,557,500
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	Yes
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2

XML 22 R4.htm IDEA: XBRL DOCUMENT

STATEMENTS OF OPERATIONS (unaudited) (USD $)	3 Months Ended		6 Months Ended		22 Months Ended
STATEMENTS OF OPERATIONS (unaudited) (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
General and administrative expenses:
Professional fees	$ 3,088	$ 4,781	$ 9,216	$ 19,085	$ 38,484
Other	1,461	1,338	2,649	2,407	7,245
Total general and administrative expenses	4,549	6,119	11,865	21,492	45,729
Net Loss	$ (4,549)	$ (6,119)	$ (11,865)	$ (21,492)	$ (45,729)
Net loss per share, basic and diluted	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average shares outstanding, basic and diluted	5,557,500	5,557,500	5,557,500	5,557,500

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

XML 23 R5.htm IDEA: XBRL DOCUMENT

STATEMENTS OF CASH FLOWS (unaudited) (USD $)	6 Months Ended		22 Months Ended
STATEMENTS OF CASH FLOWS (unaudited) (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
CASH FLOWS FROM OPERATIONS
NET LOSS	$ (11,865)	$ (21,492)	$ (45,729)
Adjustments to reconcile net loss to cash used by operating activities
Increase in accrued expenses	750	1,948	750
CASH FLOWS USED IN OPERATING ACTIVITIES	(11,115)	(19,544)	(44,979)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sale of common stock			46,550
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES			46,550
NET CHANGE IN CASH	(11,115)	(19,544)	1,571
Cash, beginning of period	12,686	41,822
Cash, end of period	1,571	22,278	1,571
SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid
Income tax paid

XML 24 R10.htm IDEA: XBRL DOCUMENT

ADVANCE FROM SHAREHOLDER (Details)	9 Months Ended
ADVANCE FROM SHAREHOLDER (Details)	Jun. 30, 2013
Loan facility	A shareholder of the Company has offered a shareholder loan facility up to $100,000. The loan facility is unsecured and bears interest at 5% per annum and is payable on demand after June 30, 2013

XML 25 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 10 49 1 false 0 0 false 3 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://www.gaiaremedies.com/20120930/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 000020 - Statement - BALANCE SHEETS (unaudited) Sheet http://www.gaiaremedies.com/20120930/role/idr_BALANCESHEETSUnaudited BALANCE SHEETS (unaudited) false false R3.htm 000030 - Statement - BALANCE SHEETS (unaudited) (parenthetical) Sheet http://www.gaiaremedies.com/20120930/role/idr_BALANCESHEETSUnauditedParenthetical BALANCE SHEETS (unaudited) (parenthetical) false false R4.htm 000040 - Statement - STATEMENTS OF OPERATIONS (unaudited) Sheet http://www.gaiaremedies.com/20120930/role/idr_STATEMENTSOFOPERATIONSUnaudited STATEMENTS OF OPERATIONS (unaudited) false false R5.htm 000050 - Statement - STATEMENTS OF CASH FLOWS (unaudited) Sheet http://www.gaiaremedies.com/20120930/role/idr_STATEMENTSOFCASHFLOWSUnaudited STATEMENTS OF CASH FLOWS (unaudited) false false R6.htm 000060 - Disclosure - NATURE OF BUSINESS Sheet http://www.gaiaremedies.com/20120930/role/idr_DisclosureNATUREOFBUSINESS NATURE OF BUSINESS false false R7.htm 000070 - Disclosure - GOING CONCERN Sheet http://www.gaiaremedies.com/20120930/role/idr_DisclosureGOINGCONCERN GOING CONCERN false false R8.htm 000080 - Disclosure - ADVANCE FROM SHAREHOLDER Sheet http://www.gaiaremedies.com/20120930/role/idr_DisclosureADVANCEFROMSHAREHOLDER ADVANCE FROM SHAREHOLDER false false R9.htm 000090 - Disclosure - GOING CONCERN (Details) Sheet http://www.gaiaremedies.com/20120930/role/idr_DisclosureGOINGCONCERNDetails GOING CONCERN (Details) false false R10.htm 000100 - Disclosure - ADVANCE FROM SHAREHOLDER (Details) Sheet http://www.gaiaremedies.com/20120930/role/idr_DisclosureADVANCEFROMSHAREHOLDERDetails ADVANCE FROM SHAREHOLDER (Details) false false All Reports Book All Reports Process Flow-Through: 000020 - Statement - BALANCE SHEETS (unaudited) Process Flow-Through: 000030 - Statement - BALANCE SHEETS (unaudited) (parenthetical) Process Flow-Through: 000040 - Statement - STATEMENTS OF OPERATIONS (unaudited) Process Flow-Through: 000050 - Statement - STATEMENTS OF CASH FLOWS (unaudited) gair-20120930.xml gair-20120930.xsd gair-20120930_cal.xml gair-20120930_def.xml gair-20120930_lab.xml gair-20120930_pre.xml true true